SK282353B6 - Farmaceutický prostriedok na intravenózne podanie - Google Patents

Farmaceutický prostriedok na intravenózne podanie Download PDF

Info

Publication number
SK282353B6
SK282353B6 SK512-98A SK51298A SK282353B6 SK 282353 B6 SK282353 B6 SK 282353B6 SK 51298 A SK51298 A SK 51298A SK 282353 B6 SK282353 B6 SK 282353B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutically acceptable
formula
butyloxy
phenyl
piperidin
Prior art date
Application number
SK512-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK51298A3 (en
Inventor
Karl M. Gelotte
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SK51298A3 publication Critical patent/SK51298A3/sk
Publication of SK282353B6 publication Critical patent/SK282353B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK512-98A 1995-10-27 1996-10-23 Farmaceutický prostriedok na intravenózne podanie SK282353B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (2)

Publication Number Publication Date
SK51298A3 SK51298A3 (en) 1998-12-02
SK282353B6 true SK282353B6 (sk) 2002-01-07

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-98A SK282353B6 (sk) 1995-10-27 1996-10-23 Farmaceutický prostriedok na intravenózne podanie

Country Status (35)

Country Link
EP (1) EP0859634B1 (xx)
JP (1) JP3452367B2 (xx)
KR (1) KR100362799B1 (xx)
CN (1) CN1158107C (xx)
AT (1) ATE213648T1 (xx)
AU (1) AU712755B2 (xx)
BG (1) BG63623B1 (xx)
BR (1) BR9610878A (xx)
CA (1) CA2234364C (xx)
CO (1) CO4770960A1 (xx)
CY (1) CY2292B1 (xx)
CZ (1) CZ290381B6 (xx)
DE (1) DE69619540T2 (xx)
DK (1) DK0859634T3 (xx)
DZ (1) DZ2110A1 (xx)
EA (1) EA000628B1 (xx)
EE (1) EE03518B1 (xx)
ES (1) ES2171749T3 (xx)
HK (1) HK1017846A1 (xx)
HU (1) HU228757B1 (xx)
IL (1) IL123790A (xx)
IS (1) IS1948B (xx)
MX (1) MX9803275A (xx)
MY (1) MY116837A (xx)
NO (1) NO324415B1 (xx)
NZ (1) NZ323134A (xx)
PL (1) PL185744B1 (xx)
PT (1) PT859634E (xx)
SA (1) SA96170527B1 (xx)
SI (1) SI0859634T1 (xx)
SK (1) SK282353B6 (xx)
TR (1) TR199800716T2 (xx)
TW (1) TW385248B (xx)
UA (1) UA45423C2 (xx)
WO (1) WO1997015328A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
IL123790A0 (en) 1998-10-30
CA2234364A1 (en) 1997-05-01
BG63623B1 (bg) 2002-07-31
UA45423C2 (uk) 2002-04-15
DE69619540D1 (de) 2002-04-04
CN1200676A (zh) 1998-12-02
EP0859634A1 (en) 1998-08-26
MX9803275A (es) 1998-09-30
IS1948B (is) 2004-10-13
NO324415B1 (no) 2007-10-08
EP0859634B1 (en) 2002-02-27
EA000628B1 (ru) 1999-12-29
IS4699A (is) 1998-03-24
CN1158107C (zh) 2004-07-21
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
NO981869D0 (no) 1998-04-24
CY2292B1 (en) 2003-07-04
IL123790A (en) 2001-11-25
ATE213648T1 (de) 2002-03-15
PL185744B1 (pl) 2003-07-31
PT859634E (pt) 2002-07-31
HUP9902521A2 (hu) 1999-12-28
CO4770960A1 (es) 1999-04-30
CA2234364C (en) 2000-02-08
NO981869L (no) 1998-04-24
WO1997015328A1 (en) 1997-05-01
KR100362799B1 (ko) 2003-07-16
NZ323134A (en) 1999-11-29
SA96170527B1 (ar) 2005-12-21
TW385248B (en) 2000-03-21
EE03518B1 (et) 2001-10-15
KR19990067020A (ko) 1999-08-16
BR9610878A (pt) 1999-07-13
DZ2110A1 (fr) 2002-07-22
BG102405A (en) 1999-08-31
EA199800336A1 (ru) 1998-10-29
CZ127898A3 (cs) 1998-10-14
DE69619540T2 (de) 2002-08-22
EE9800134A (et) 1998-10-15
ES2171749T3 (es) 2002-09-16
AU712755B2 (en) 1999-11-18
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
SK51298A3 (en) 1998-12-02
CZ290381B6 (cs) 2002-07-17
JP3452367B2 (ja) 2003-09-29
SI0859634T1 (en) 2002-04-30
PL326419A1 (en) 1998-09-14
MY116837A (en) 2004-04-30
TR199800716T2 (xx) 1998-07-21
HK1017846A1 (en) 1999-12-03
HU228757B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
BRPI0608656A2 (pt) composiÇÕes farmacÊuticas para tratamento de trombose
JP2008539269A (ja) 疼痛を治療するための方法および組成物
BR112016015763B1 (pt) Preparação farmacêutica incluindo composto de ácido piridilaminoacético, e, uso da mesma
SK7502002A3 (en) Pharmaceutical combinations
BR112020002325A2 (pt) composições farmacêuticas
US6730685B1 (en) Formulation of substituted benzimidazoles
SK282353B6 (sk) Farmaceutický prostriedok na intravenózne podanie
ES2950461T3 (es) Agente preventivo y/o terapéutico que contiene un compuesto de ácido piridilaminoacético para el tratamiento de una enfermedad que involucra una presión intraocular muy elevada
CA2046412A1 (en) Treatment of inflammatory diseases with polyoxyethylenesorbitan mono-higher-fatty acid esters
US5972967A (en) Compositions for inhibiting platelet aggregation
US5733919A (en) Compositions for inhibiting platelet aggregation
US5965581A (en) Compositions for inhibiting platelet aggregation
JP2012180346A (ja) 親水性薬物の薬物移行性を改善した水性組成物
JPWO2003026636A1 (ja) 血栓・塞栓形成の抑制剤
RU2813780C2 (ru) Терапевтические соединения и композиции
WO2017170626A1 (ja) 水性液剤
JPH09104627A (ja) アパファントを主薬とする水性点眼剤
UA125537C2 (uk) Фармацевтична композиція інгібітора плазмового калікреїну, способи її отримання (варіанти) і застосування
WO2016204239A1 (ja) TAFIa阻害剤とプラスミノーゲンアクチベータの組み合わせ
JP2004250441A (ja) 血小板大凝集塊の形成阻害剤

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20141023